Skip to content

5-MeO-DMT: all studies

Page 109 of 110: studies 1,081 to 1,090 of 1,097, newest first. Back to the 5-MeO-DMT overview

Research

Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain

Brain Research August 1, 1975 Kern von Hungen, Sidney Roberts, Diane F. Hill 70 citations

Investigations were carried out on the interactions of the hallucinogenic drug, D-lysergic acid diethylamide (D-LSD), and other serotonin antagonists with catecholamine-sensitive adenylate cyclase systems in cell-free preparations from different regions of rat brain. In equimolar concentration, D-LSD, 2-brono-D-lysergic acid diethylamide (BOL), or methysergide (UML) strongly blocked maximal...

Mammalian Biosynthesis of Potential Psychotogens Derived from Dopamine

Catecholamines and Behavior · 1 1975 Arnold J. Friedhoff, Jack W. Schweitzer 1 citation

Normal mental functions can be disrupted by many kinds of drugs. Hallucinogens are of special interest because of their ability to impair higher centers without producing substantial effect on other functions of the central nervous system. While the mechanism of action of hallucinogens has not been clarified, the striking structural resemblance between certain of these agents and several...

DOI: 10.1007/978-1-4684-3135-3_7 (opens in new tab) Full text (opens in new tab) Biogenic amine Comt activity Catecholamine metabolite Cetic acid +1

OCCURRENCE OF PSYCHODELIC SUBSTANCES IN SOME INDIAN MEDICINAL PLANTS

Planta Medica March 1, 1972 S. P. Ghosal 8 citations

Over two dozen Indian medicinal plants belonging to the families Leguminosae, Gramineae, and Malpighiaceae have been screened for potential psychodelic substances. The evaluation of only the indole bearing plants is reported here. Localization of about forty indole alkaloids, representing four broad structural types, viz., indole–3–alkylamines, carboxylated tryptamines, β–carbolines, and...

Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

British Journal of Pharmacology December 1, 1971 A. David Smith 179 citations

1. The hyperactivity and hyperpyrexia produced by L-tryptophan in rats treated with a monoamine oxidase inhibitor was inhibited by chlorpromazine.2. Chlorpromazine did not inhibit the increased rate of synthesis of brain 5-hydroxytryptamine (5-HT) produced by tryptophan loading.3. Hyperactivity and hyperpyrexia were also produced by 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) in rats....

DOI: 10.1111/j.1476-5381.1971.tb07222.x (opens in new tab) Serotonin Chlorpromazine Monoamine oxidase inhibitor Monoamine neurotransmitter +8

Characterization of Alkaloids in Palatable and Unpalatable Clones of Phalaris arundinacea L1

Crop Science March 1, 1971 Martin L Williams, R. F. Barnes, John M. Cassady 20 citations

We determined the types and amounts of alkaloids found in four reed canarygrass ( Phalaris arundinacea L.) genotypes that differed in palatability. The palatability differences had been demonstrated previously in cafeteria grazing trials with lambs. The following alkaloids were identified in reed canarygrass by combinations of gas‐liquid chromatography, thin‐layer chromatography, and mass...

DOI: 10.2135/cropsci1971.0011183x001100020014x (opens in new tab) Phalaris arundinacea Palatability Cafeteria Dry matter +4

ALKALOIDS OFMUCUNA PRURIENSCHEMISTRY AND PHARMACOLOGY

Planta Medica February 1, 1971 S. Ghosal, Saumitra Sen Singh, S. Bhattacharya 39 citations

Four indole–3–alkylamines, viz., N,N–dimethyltryptamine, its N b –oxide, bufo–tenine, and 5–methoxy–N,N–dimethyltryptamine along with two uncharacterized 5–oxy–indole–3–alkylamines and a β–carboline were isolated from the various parts, except the trichomes of pods, of Mucuna pruriens DC. The trichomes of pods afforded only serotonin. Besides these, choline was found in all parts of the plant....

Psychological Effects and Metabolism of N,N-diethyltryptamine in Man

Archives of General Psychiatry September 1, 1966 Stephen Szára 33 citations

SIMPLE INDOLE derivatives like the alkylated tryptamines, N,N-dimethyltryptamine (DMT) and N,N-diethyltryptamine (DET), produce psychotogenic-like symptoms similar to lysergic acid diethyemide (LSD) and mescaline.1-4 One of the important metabolic pathways of DET has been shown to be by 6-hydroxylation.5The known metabolic pathways of DET are summarized in Fig 1. Other investigators have...

Enzymatic Formation of Psychotomimetic Metabolites from Normally Occurring Compounds

Science August 4, 1961 Julius Axelrod 183 citations

An enzyme has been found that N-methylates serotonin and tryptamine to psychotomimetic metabolites, bufotenine and N,N-dimethyltryptamine. This enzyme is highly localized in the rabbit lung and also N-methylates phenylethylamine derivatives such as tyramine, phenylethylamine, mescaline, and dopamine.

Ayahuasca: What Healthcare Providers Need to Know.

Journal of Addictions Nursing Deana Goldin, Deborah Salani 2 citations

Ayahuasca is a pan-Amazonian botanical hallucinogenic decoction made from a mixture of the bark of the Banisteriopsis caapi plant, containing a monoamine oxidase inhibitor, and Psychotria viridis (Rubiaceae) or Diplopterys cabrerana shrubs containing a serotonergic 2A receptor agonist, N,N-dimethyltryptamine, a powerful psychoactive substance. Ayahuasca is a traditional psychoactive sacrament...

Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial.

Journal of Clinical Psychopharmacology Lucas Silva Rodrigues, José Augusto Silva Reis, Giordano Novak Rossi et al. 8 citations

Ayahuasca is a South American plant hallucinogen rich in the psychedelic N,N-dimethyltryptamine and β-carbolines (mainly harmine). Preclinical and observational studies suggest that ayahuasca exerts beneficial effects in substance use disorders, but these potentials were never assessed in a clinical trial. Single-center, single-blind, feasibility, proof-of-concept study, assessing the effects...

DOI: 10.1097/jcp.0000000000001872 (opens in new tab) Full text (opens in new tab) Ayahuasca medicine Psychedelics Addiction treatment Substance abuse +1